Fig. 4

A Percentage reduction (y-axis) in non-hospitalised and hospitalised RSV cases and RSV-associated deaths in response to maternal vaccination or monoclonal antibody use. Solid horizontal lines show the reduction as a percentage of the variables’ pre-intervention median values, which are displayed by the numbers at the top of panels (the pre-intervention values are the same for MV and mAb). Horizontal lines show the median values. Boxes show 50% and whiskers the 95% credible intervals. B Percentage reduction in subtypes of disease burden (DALYs) in response to maternal vaccination or monoclonal antibody campaigns. C Percentage reduction in costs of disease burden (USD) in response to maternal vaccination or monoclonal antibody campaigns